SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-20-008386
Filing Date
2020-05-12
Accepted
2020-05-12 16:42:57
Documents
6
Period of Report
2020-05-07
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.02: Results of Operations and Financial Condition
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm 8-K 40424
2 ex10-1.htm EX-10.1 23054
3 ex10-2.htm EX-10.2 21297
4 ex10-3.htm EX-10.3 20802
5 ex99-1.htm EX-99.1 121653
6 ex99-1_001.jpg GRAPHIC 2465
  Complete submission text file 0001493152-20-008386.txt   232221
Mailing Address 15 CUSHING IRVINE CA 92618
Business Address 15 CUSHING IRVINE CA 92618 949-409-7600
OncoCyte Corp (Filer) CIK: 0001642380 (see all company filings)

IRS No.: 271041563 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37648 | Film No.: 20869682
SIC: 2835 In Vitro & In Vivo Diagnostic Substances